2nd Enhancing Drug Bioavailability & Solubility
21 Jan 2013 - 23 Jan 2013 - Boston, MA, USA
Based on the successes of our inaugural Enhancing Drug Bioavailability and Solubility Conference in 2012, ExL Pharma brings together the industry’s leading formulation experts together to share and discuss emerging drug bioavailability and solubility enhancement strategies. Learn from the industry's most accomplished drug formulation and preformulation experts. Join 125+ executives from 80+ leading organizations to discuss and hear unique take-home examples, case studies and multiple formulation and preformulation strategies to assist in improving drug solubility and bioavailability, maximizing exposure, and reducing time-to-market on future drug products.
What Will You Learn?
Rationale formulation design for poorly soluble compounds
Pharmaceutical formulation development strategies: Considerations for successful product development
Improving oral bioavailability for poorly water-soluble drug candidates
Experimental methods for investigating and maintaining supersaturation to enhance drug bioavailability
Solubilities of crystalline drugs in polymers
Solubilization approaches for parenteral routes of administration
Product diversification and enhancement through pre-formulation technologies
Patent opportunities for solubility solutions
Enhancing API bioavailability via nanotechnology for drug delivery
Application of nanotechnology for the enhancement of skin permeability for poorly soluble compounds
Improving oral modified release dosage forms